Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Evolutionary Relationships through Genome Comparisons02:54

Evolutionary Relationships through Genome Comparisons

6.8K
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating Genetic, Environmental, Cognitive, and Temperament Data for ADHD Prediction in Explainable Deep Learning Models.

medRxiv : the preprint server for health sciences·2026
Same author

In memoriam - Ming T. Tsuang, M.D., Ph.D., D.Sc.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Identification of hub genes involved in early-onset schizophrenia: from genetic susceptibility to predicted regulated gene expression.

Molecular psychiatry·2026
Same author

Psychiatric and neurological predictors of early ADHD medication discontinuation across the lifespan: a multinational study.

BMJ mental health·2026
Same author

Predicted brain-regional gene expression patterns in individuals living with Alzheimer's disease.

Neurobiology of aging·2026
Same author

MicroRNAs in metabolic effects with atypical antipsychotics-a scoping review.

Therapeutic advances in psychopharmacology·2026

Related Experiment Video

Updated: Jan 11, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

24.8K

Using genomic context informed genotype data and within-model ancestry adjustment to classify type 2 diabetes.

Eric J Barnett1, Yanli Zhang-James2, Jonathan L Hess2

  • 1Department of Psychiatry and Behavioral Sciences and Department of Neuroscience and Physiology, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, NY, USA.

Communications Medicine
|November 18, 2025
PubMed
Summary
This summary is machine-generated.

New neural network models integrating genomic context improve prediction of type 2 diabetes risk, outperforming traditional polygenic risk scores. These advances represent a step towards clinical utility for genetic risk prediction in complex disorders.

More Related Videos

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.3K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.5K

Related Experiment Videos

Last Updated: Jan 11, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

24.8K
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.3K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.5K

Area of Science:

  • Genomics
  • Machine Learning
  • Computational Biology

Background:

  • Complex genetic disorders are difficult to predict using genetic data despite high heritability.
  • Existing genomic research highlights polygenic inheritance and functional genomic annotations but lacks optimal risk models.
  • Advanced methods are needed to enhance the clinical utility of genetic risk prediction.

Purpose of the Study:

  • To develop and test a novel modeling framework integrating genomic context with genotype data for improved complex disease risk prediction.
  • To evaluate the performance of convolutional neural networks against traditional polygenic risk scores for type 2 diabetes.
  • To assess the robustness of the models by accounting for genetic ancestry.

Main Methods:

  • A modeling framework using genomic context annotations and genotype data as input for convolutional neural networks was developed.
  • A matched-pairs dataset of individuals with and without type 2 diabetes was used for model training and comparison.
  • Adversarial tasks were employed to remove genetic ancestry prediction capabilities while preserving risk prediction performance.

Main Results:

  • Neural networks utilizing genotype data (AUC: 0.66) and context-informed genotype data (AUC: 0.65) outperformed polygenic risk score approaches for type 2 diabetes classification.
  • Adversarial ancestry tasks successfully removed ancestry predictability without compromising model performance.
  • The study demonstrates the efficacy of integrating genomic context into neural network models.

Conclusions:

  • Neural network approaches integrating genotype data with genomic context and accounting for ancestry show improved classification performance.
  • While not yet sufficient for clinical application in type 2 diabetes, these incremental advances contribute to the future utility of genetic risk prediction.
  • The developed framework offers a promising direction for advancing genetic risk models for complex disorders.